Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

FDA Initiatives Impact Lyophilisation Process Development and Optimisation

Quality by Design and Process Analytical Technology are two new FDA concepts which are challenging traditional approaches to manufacturing using lyophilisation. Mark Shon at SP Scientific investigates.

Mark Shon, SP Scientific investigates (June 2013)

Keywords: Lyophilisation Quality by Design (QBD) Process Analytical Technology (PAT) Tunable diode laser absorption spectrometry (TDLAS)

    View full article    |    Back to Ingredients, Formulations and Finishing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |